Literature DB >> 20003640

Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications.

L Acedo1, J Díez-Domingo, J-A Moraño, R-J Villanueva.   

Abstract

We propose an age-structured mathematical model for respiratory syncytial virus in which children aged <1 year are especially considered. Real data on hospitalized children in the Spanish region of Valencia were used in order to determine some seasonal parameters of the model. Weekly predictions of the number of children aged <1 year that will be hospitalized in the following years in Valencia are presented using this model. Results are applied to estimate the regional cost of paediatric hospitalizations and to perform a cost-effectiveness analysis of possible vaccination strategies.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20003640     DOI： 10.1017/S0950268809991373

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN： 0950-2688            Impact factor:   2.451


  12 in total

1.  Number needed to immunize to prevent RSV with extended half-life monoclonal antibody.

Authors:  Lyn Finelli; Yoonyoung Choi; Edward Goldstein
Journal:  Vaccine       Date:  2020-06-26       Impact factor: 3.641

2.  Modelling effectiveness of herd level vaccination against Q fever in dairy cattle.

Authors:  Aurélie Courcoul; Lenny Hogerwerf; Don Klinkenberg; Mirjam Nielen; Elisabeta Vergu; François Beaudeau
Journal:  Vet Res       Date:  2011-05-23       Impact factor: 3.683

3.  Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting.

Authors:  Timothy M Kinyanjui; Thomas A House; Moses C Kiti; Patricia A Cane; David J Nokes; Graham F Medley
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

4.  Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States.

Authors:  Virginia E Pitzer; Cécile Viboud; Wladimir J Alonso; Tanya Wilcox; C Jessica Metcalf; Claudia A Steiner; Amber K Haynes; Bryan T Grenfell
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

5.  Unexpected Infection Spikes in a Model of Respiratory Syncytial Virus Vaccination.

Authors:  Robert J Smith; Alexandra B Hogan; Geoffry N Mercer
Journal:  Vaccines (Basel)       Date:  2017-05-18

6.  Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants.

Authors:  Gabriel Rainisch; Bishwa Adhikari; Martin I Meltzer; Gayle Langley
Journal:  Vaccine       Date:  2019-11-16       Impact factor: 3.641

7.  Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data.

Authors:  Marina Treskova; Francisco Pozo-Martin; Stefan Scholz; Viktoria Schönfeld; Ole Wichmann; Thomas Harder
Journal:  Pharmacoeconomics       Date:  2021-01-19       Impact factor: 4.981

Review 8.  Strategic priorities for respiratory syncytial virus (RSV) vaccine development.

Authors:  L J Anderson; P R Dormitzer; D J Nokes; R Rappuoli; A Roca; B S Graham
Journal:  Vaccine       Date:  2013-04-18       Impact factor: 3.641

9.  Modelling the seasonal epidemics of respiratory syncytial virus in young children.

Authors:  Hannah C Moore; Peter Jacoby; Alexandra B Hogan; Christopher C Blyth; Geoffry N Mercer
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

10.  Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data.

Authors:  Koen B Pouwels; Sefika E Bozdemir; Selen Yegenoglu; Solmaz Celebi; E David McIntosh; Serhat Unal; Maarten J Postma; Mustafa Hacimustafaoglu
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.